Personalised Cancer Medicine

Future Crafting in the Genomic Era

AvAnne Kerr,Choon Key Chekar

Inbunden, Engelska, 2021

Del 1 i serien Inscriptions

434 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

What does it mean to personalise cancer medicine? Drawing on an ethnographic study with cancer patients, carers and practitioners in the UK, this book traces their efforts to access and interpret novel genomic tests, information and treatments as they craft personal and collective futures. Exploring multiple experiences of new diagnostic tests, research programmes and trials, advocacy and experimental therapies, the authors chart the different kinds of care and work involved in efforts to personalise cancer medicine, as well as the ways in which benefits and opportunities are unevenly realised and distributed.Comparing these experiences with policy and professional accounts of the ‘big’ future of personalised healthcare, the authors show how hope and care are multi-faceted, contingent and, at times, frustrated in the everyday complexities of living and working with cancer.An electronic edition of this book is freely available under a Creative Commons (CC BY-NC-ND) licence.

Produktinformation

Utgivningsdatum:2021-01-05
Mått:138 x 216 x 17 mm
Vikt:481 g
Format:Inbunden
Språk:Engelska
Serie:Inscriptions
Antal sidor:288
Förlag:Manchester University Press
ISBN:9781526141026

Utforska kategorier

Antropologi inom Samhälle och politik
Rättsliga frågor i hälso- och sjukvården inom Medicin
Medicinsk genetik inom Medicin

Mer om författaren

Anne Kerr is Professor of Sociology at the University of GlasgowChoon Key Chekar is a Senior Research Associate at the University of LancasterEmily Ross is a Research Fellow at the University of EdinburghJulia Swallow is a Wellcome Trust Senior Research Fellow in Humanities and Social Sciences at the University of EdinburghSarah Cunningham-Burley is Professor of Medical and Family Sociology at the University of Edinburgh

Innehållsförteckning

Introduction: Exploring personalised cancer medicine1 Personalising cancer treatment and diagnosis through genomic medicine2 Genomic techniques in standard care: Gene expression profiling in early stage breast cancer3 Molecular profiling for advanced gynaecological cancer: prolonging foreshortened futures4 Optimising personalisation: Adaptive trials for intractable cancers5 Genomics at Scale: Participation to build the bioeconomy6 Going Private: Digital culture and personalised medicine7 At the limits of participationConclusion: Future craftingBibliographyIndex